Audentes Therapeutics, Inc.

NASDAQ: BOLD
$59.97
+$0.00 (+0.0%)
Closing price January 15, 2020

Top Analyst Upgrades and Downgrades: Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon, Sage Therapeutics, Target, Tesla, Trade Desk, Yext and More
Friday's top analyst upgrades and downgrades included Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon Athletica, Sage Therapeutics, Target, Tesla, Trade Desk and Yext.
Jon C. Ogg
3 years ago
Last Updated: 2 years ago

Are Audentes Shareholders Getting Enough in the Acquisition?
Audentes Therapeutics shares more than doubled on Tuesday after the firm announced that it would be acquired by Astellas. Although Audentes has only been public for just over three years, this...
Chris Lange
3 years ago
Last Updated: 2 years ago

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Beyond Meat, CommScope, Enphase, Nabors, Netflix, Nike, Roku, Tesla, Uber, Williams Companies and More
Tuesday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Beyond Meat, CommScope, Enphase Energy, Nabors Industries, Netflix, Nike, Roku, Tesla, Uber Technologies and...
Jon C. Ogg
3 years ago
Last Updated: 1 year ago

7 Biotechs With Catalysts in the Next Month
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Chris Lange
3 years ago
Last Updated: 2 years ago